 
		
		
		Enhancing CVD Risk Assessment: Integrating Genetic Risk for Improved Prediction
		
		In a population-based study, researchers found that both the relative genetic risk, assessed through a polygenic risk score and the absolute clinical risk, evaluated by SCORE2, independently contribute to an individual's overall CVD risk.